Skip to main content

Advertisement

SpringerLink
Log in

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma

  • REVIEW ARTICLE
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) is well known as a typical angiogenic tumor, especially in the moderately to poorly differentiated type. Such clinicopathological characteristics are not only useful for imaging diagnosis but are also applicable to the treatment of HCC. In addition, recent molecular studies have revealed that angiogenesis is closely related to hepatocarcinogenesis. In this review, the molecular mechanism of HCC angiogenesis and the antiangiogenic prevention of HCC are reviewed to introduce the latest trends in antiangiogenic treatment of cancers, including HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J Folkman (1971) ArticleTitleTumor angiogenesis: therapeutic implications N Engl J Med 285 IssueID21 1182–1186 Occurrence Handle1:STN:280:CS2D3cfkvFc%3D Occurrence Handle4938153

    CAS  PubMed  Google Scholar 

  2. N Ferrara RS Kerbel (2005) ArticleTitleAngiogenesis as a therapeutic target Nature (Lond) 438 IssueID7070 967–794 Occurrence Handle1:CAS:528:DC%2BD2MXhtlSksrnI

    CAS  Google Scholar 

  3. D Hanahan J Folkman (1996) ArticleTitlePatterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353–364 Occurrence Handle10.1016/S0092-8674(00)80108-7 Occurrence Handle1:CAS:528:DyaK28XltVSks7s%3D Occurrence Handle8756718

    Article  CAS  PubMed  Google Scholar 

  4. P Carmeliet RK Jain (2000) ArticleTitleAngiogenesis in cancer and other diseases Nature (Lond) 407 IssueID6801 249–257 Occurrence Handle1:CAS:528:DC%2BD3cXmvVSls74%3D

    CAS  Google Scholar 

  5. T Asahara T Murohara A Sullivan et al. (1997) ArticleTitleIsolation of putative progenitor endothelial cells for angiogenesis Science 275 IssueID5302 964–967 Occurrence Handle10.1126/science.275.5302.964 Occurrence Handle1:CAS:528:DyaK2sXht1Clu7k%3D Occurrence Handle9020076

    Article  CAS  PubMed  Google Scholar 

  6. N Kawahara M Ono K Taguchi et al. (1998) ArticleTitleEnhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma Hepatology 28 IssueID6 1512–1517 Occurrence Handle10.1002/hep.510280610 Occurrence Handle1:CAS:528:DyaK1cXotFSgtr4%3D Occurrence Handle9828214

    Article  CAS  PubMed  Google Scholar 

  7. RT Poon KK Chung ST Cheung et al. (2004) ArticleTitleClinical significance of thrombospondin 1 expression in hepatocellular carcinoma Clin Cancer Res 10 IssueID12 pt 1 4150–4157 Occurrence Handle1:CAS:528:DC%2BD2cXltFWmu7o%3D Occurrence Handle15217952

    CAS  PubMed  Google Scholar 

  8. N Ferrara (2002) ArticleTitleVEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2 IssueID10 795–803 Occurrence Handle10.1038/nrc909 Occurrence Handle1:CAS:528:DC%2BD38XnsVGrtbk%3D Occurrence Handle12360282

    Article  CAS  PubMed  Google Scholar 

  9. M Mise S Arii H Higashituji et al. (1996) ArticleTitleClinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor Hepatology 23 IssueID3 455–464 Occurrence Handle1:STN:280:BymB3cnhtVU%3D Occurrence Handle8617424

    CAS  PubMed  Google Scholar 

  10. YN Park YB Kim KM Yang C Park (2000) ArticleTitleIncreased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis Arch Pathol Lab Med 124 1061–1065 Occurrence Handle1:CAS:528:DC%2BD3cXlsFWjurc%3D Occurrence Handle10888784

    CAS  PubMed  Google Scholar 

  11. IO Ng RT Poon JM Lee et al. (2001) ArticleTitleMicrovessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma Am J Clin Pathol 116 838–845 Occurrence Handle1:CAS:528:DC%2BD38XhsVejsQ%3D%3D Occurrence Handle11764072

    CAS  PubMed  Google Scholar 

  12. XM Li ZY Tang G Zhou YK Liu SL Ye (1998) ArticleTitleSignificance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma J Exp Clin Cancer Res 17 13–17 Occurrence Handle9646228

    PubMed  Google Scholar 

  13. ON El Assal A Yamanoi Y Soda et al. (1998) ArticleTitleClinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver Hepatology 27 1554–1562 Occurrence Handle1:STN:280:DyaK1c3otFKgtA%3D%3D Occurrence Handle9620326

    CAS  PubMed  Google Scholar 

  14. R Yamaguchi H Yano A Iemura et al. (1998) ArticleTitleExpression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 68–77 Occurrence Handle1:CAS:528:DyaK1cXks1aqsLo%3D Occurrence Handle9657098

    CAS  PubMed  Google Scholar 

  15. K Sugimachi S Tanaka K Taguchi et al. (2003) ArticleTitleAngiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma J Clin Pathol 56 IssueID11 854–860 Occurrence Handle10.1136/jcp.56.11.854 Occurrence Handle1:STN:280:DC%2BD3srit1ejtA%3D%3D Occurrence Handle14600132

    Article  CAS  PubMed  Google Scholar 

  16. S Yasuda S Arii A Mori et al. (2004) ArticleTitleHexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance J Hepatol 40 IssueID1 117–123 Occurrence Handle10.1016/S0168-8278(03)00503-8 Occurrence Handle1:CAS:528:DC%2BD3sXps1Ogtr4%3D Occurrence Handle14672622

    Article  CAS  PubMed  Google Scholar 

  17. Z von Marschall T Cramer M Hocker et al. (2001) ArticleTitleDual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma Gut 48 87–96 Occurrence Handle10.1136/gut.48.1.87 Occurrence Handle1:CAS:528:DC%2BD3MXntFKmtg%3D%3D Occurrence Handle11115828

    Article  CAS  PubMed  Google Scholar 

  18. A Tsukamoto Y Kaneko T Yoshida M Ichinose S Kimura (1999) ArticleTitleRegulation of angiogenesis in human hepatomas: possible involvement of p53-inducible inhibitor of vascular endothelial cell proliferation Cancer Lett 141 79–84 Occurrence Handle1:CAS:528:DyaK1MXjs1SjsbY%3D Occurrence Handle10454246

    CAS  PubMed  Google Scholar 

  19. SW Lee YM Lee SK Bae et al. (2000) ArticleTitleHuman hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis Biochem Biophys Res Commun 268 456–461 Occurrence Handle1:CAS:528:DC%2BD3cXhtFGjs7s%3D Occurrence Handle10679226

    CAS  PubMed  Google Scholar 

  20. M Tsujii S Kawano S Tsuji et al. (1998) ArticleTitleCyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 IssueID5 705–716 Occurrence Handle10.1016/S0092-8674(00)81433-6 Occurrence Handle1:CAS:528:DyaK1cXjsl2ksbw%3D Occurrence Handle9630216

    Article  CAS  PubMed  Google Scholar 

  21. M Schmitt A Horbach R Kubitz A Frilling D Haussinger (2004) ArticleTitleDisruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion J Hepatol 41 IssueID2 274–283 Occurrence Handle10.1016/j.jhep.2004.04.035 Occurrence Handle1:CAS:528:DC%2BD2cXmt1KjsLs%3D Occurrence Handle15288477

    Article  CAS  PubMed  Google Scholar 

  22. S Arii (2004) ArticleTitleRole of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma J Hepatol 41 IssueID2 333–335 Occurrence Handle10.1016/j.jhep.2004.06.022 Occurrence Handle1:CAS:528:DC%2BD2cXmt1Kjsbo%3D Occurrence Handle15382329

    Article  CAS  PubMed  Google Scholar 

  23. RT Poon IO Ng C Lau et al. (2001) ArticleTitleCorrelation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma Am J Surg 182 298–304 Occurrence Handle10.1016/S0002-9610(01)00708-5 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Shtb0%3D Occurrence Handle11587697

    Article  CAS  PubMed  Google Scholar 

  24. H Yoshiji S Kuriyama J Yoshii et al. (2002) ArticleTitleSynergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma Hepatology 35 834–842 Occurrence Handle10.1053/jhep.2002.32541 Occurrence Handle1:CAS:528:DC%2BD38XjtFSks7w%3D Occurrence Handle11915029

    Article  CAS  PubMed  Google Scholar 

  25. S Ogasawara H Yano A Iemura T Hisaka M Kojiro (1996) ArticleTitleExpressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines Hepatology 24 198–205 Occurrence Handle1:CAS:528:DyaK28XkvFSjuro%3D Occurrence Handle8707262

    CAS  PubMed  Google Scholar 

  26. M Kin M Sata T Ueno et al. (1997) ArticleTitleBasic fibroblast growth factor regulates proliferation and motility of human hepatoma cells by an autocrine mechanism J Hepatol 27 677–687 Occurrence Handle10.1016/S0168-8278(97)80085-2 Occurrence Handle1:CAS:528:DyaK2sXmvFyhur8%3D Occurrence Handle9365044

    Article  CAS  PubMed  Google Scholar 

  27. K Kage N Fujita T Oh-hara et al. (1999) ArticleTitleBasic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone Biochem Biophys Res Commun 254 IssueID1 259–263 Occurrence Handle10.1006/bbrc.1998.9875 Occurrence Handle1:CAS:528:DyaK1MXntFCmtA%3D%3D Occurrence Handle9920767

    Article  CAS  PubMed  Google Scholar 

  28. S Uematsu T Higashi K Nouso et al. (2005) ArticleTitleAltered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma J Gastroenterol Hepatol 20 IssueID4 583–588 Occurrence Handle10.1111/j.1440-1746.2005.03726.x Occurrence Handle1:CAS:528:DC%2BD2MXls1aqt7g%3D Occurrence Handle15836707

    Article  CAS  PubMed  Google Scholar 

  29. Y Motoo N Sawabu Y Yamaguchi T Terada Y Nakanuma (1993) ArticleTitleSinusoidal capillarization of human hepatocellular carcinoma: possible promotion by fibroblast growth factor Oncology 50 270–274 Occurrence Handle1:CAS:528:DyaK3sXlsFaksrk%3D Occurrence Handle8388557

    CAS  PubMed  Google Scholar 

  30. F Balkwill A Mantovani (2001) ArticleTitleInflammation and cancer: back to Virchow? Lancet 357 IssueID9255 539–545 Occurrence Handle10.1016/S0140-6736(00)04046-0 Occurrence Handle1:CAS:528:DC%2BD3MXhsVKltb0%3D Occurrence Handle11229684

    Article  CAS  PubMed  Google Scholar 

  31. MJ Gorrin Rivas S Arii M Furutani et al. (1998) ArticleTitleExpression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance Hepatology 28 IssueID4 986–993 Occurrence Handle1:STN:280:DyaK1cvivFGmug%3D%3D Occurrence Handle9755235

    CAS  PubMed  Google Scholar 

  32. J Akiba H Yano S Ogasawara K Higaki M Kojiro (2001) ArticleTitleExpression and function of interleukin-8 in human hepatocellular carcinoma Int J Oncol 18 IssueID2 257–264 Occurrence Handle1:CAS:528:DC%2BD3MXnvF2nsA%3D%3D Occurrence Handle11172590

    CAS  PubMed  Google Scholar 

  33. M Perez-Ruiz J Ros M Morales-Ruiz et al. (1999) ArticleTitleVascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide Hepatology 29 IssueID4 1057–1063 Occurrence Handle1:CAS:528:DyaK1MXisVKgsL8%3D Occurrence Handle10094946

    CAS  PubMed  Google Scholar 

  34. T Kawakita K Shiraki Y Yamanaka et al. (2004) ArticleTitleFunctional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis Biochem Biophys Res Commun 318 IssueID3 726–733 Occurrence Handle10.1016/j.bbrc.2004.04.084 Occurrence Handle1:CAS:528:DC%2BD2cXktV2mtr0%3D Occurrence Handle15144899

    Article  CAS  PubMed  Google Scholar 

  35. A Jakubowski C Ambrose M Parr et al. (2005) ArticleTitleTWEAK induces liver progenitor cell proliferation J Clin Invest 115 IssueID9 2330–2340 Occurrence Handle10.1172/JCI23486 Occurrence Handle1:CAS:528:DC%2BD2MXhtVSjsrbL Occurrence Handle16110324

    Article  CAS  PubMed  Google Scholar 

  36. N Fausto (2005) ArticleTitleTweaking liver progenitor cells Nat Med 11 IssueID10 1053–1054 Occurrence Handle10.1038/nm1005-1053 Occurrence Handle1:CAS:528:DC%2BD2MXhtVOiurbJ Occurrence Handle16211039

    Article  CAS  PubMed  Google Scholar 

  37. S Tanaka M Mori Y Sakamoto et al. (1999) ArticleTitleBiologic significance of angiopoietin-2 expression in human hepatocellular carcinoma J Clin Invest 103 341–345 Occurrence Handle1:CAS:528:DyaK1MXovVKnuw%3D%3D Occurrence Handle9927494

    CAS  PubMed  Google Scholar 

  38. S Davis TH Aldrich PF Jones et al. (1996) ArticleTitleIsolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning Cell 87 1161–1169 Occurrence Handle10.1016/S0092-8674(00)81812-7 Occurrence Handle1:CAS:528:DyaK2sXit1Cqsw%3D%3D Occurrence Handle8980223

    Article  CAS  PubMed  Google Scholar 

  39. PC Maisonpierre C Suri PF Jones et al. (1997) ArticleTitleAngiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 55–60 Occurrence Handle10.1126/science.277.5322.55 Occurrence Handle1:CAS:528:DyaK2sXksVyhu78%3D Occurrence Handle9204896

    Article  CAS  PubMed  Google Scholar 

  40. KA Gill NP Brindle (2005) ArticleTitleAngiopoietin-2 stimulates migration of endothelial progenitors and their interaction with endothelium Biochem Biophys Res Commun 336 IssueID2 392–396 Occurrence Handle10.1016/j.bbrc.2005.08.097 Occurrence Handle1:CAS:528:DC%2BD2MXhtVWns7nP Occurrence Handle16129411

    Article  CAS  PubMed  Google Scholar 

  41. SJ Mandriota MS Pepper (1998) ArticleTitleRegulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia Circ Res 83 IssueID8 852–859 Occurrence Handle1:CAS:528:DyaK1cXntVCrtro%3D Occurrence Handle9776732

    CAS  PubMed  Google Scholar 

  42. S Tanaka JR Wands S Arii (2006) ArticleTitleInduction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis J Hepatol 44 IssueID1 233–235 Occurrence Handle10.1016/j.jhep.2005.09.012 Occurrence Handle1:CAS:528:DC%2BD2MXht12ktLvE Occurrence Handle16290311

    Article  CAS  PubMed  Google Scholar 

  43. B Witzenbichler PC Maisonpierre P Jones GD Yancopoulos JM Isner (1998) ArticleTitleChemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 J Biol Chem 273 IssueID29 18514–18521 Occurrence Handle10.1074/jbc.273.29.18514 Occurrence Handle1:CAS:528:DyaK1cXkvVCgt74%3D Occurrence Handle9660821

    Article  CAS  PubMed  Google Scholar 

  44. GD Yancopoulos S Davis NW Gale et al. (2000) ArticleTitleVascular-specific growth factors and blood vessel formation Nature (Lond) 407 242–248 Occurrence Handle1:CAS:528:DC%2BD3cXmvVSlsrY%3D

    CAS  Google Scholar 

  45. S Tanaka K Sugimachi Y Yamashita et al. (2002) ArticleTitleTie2 vascular endothelial receptor expression and function in hepatocellular carcinoma Hepatology 35 861–867 Occurrence Handle10.1053/jhep.2002.32535 Occurrence Handle1:CAS:528:DC%2BD38XjtFSksL4%3D Occurrence Handle11915032

    Article  CAS  PubMed  Google Scholar 

  46. S Tanaka K Sugimachi Y Yamashita et al. (2003) ArticleTitleAngiogenic switch as a molecular target of malignant tumors J Gastroenterol 38 IssueIDsuppl 15 93–97 Occurrence Handle1:CAS:528:DC%2BD3sXjtlelurY%3D Occurrence Handle12698880

    CAS  PubMed  Google Scholar 

  47. MJ Thun MM Namboodiri CW Heath SuffixJr (1991) ArticleTitleAspirin use and reduced risk of fatal colon cancer N Engl J Med 325 IssueID23 1593–1596 Occurrence Handle1:STN:280:By2D2cblvFE%3D Occurrence Handle1669840

    CAS  PubMed  Google Scholar 

  48. H Koga (2003) ArticleTitleHepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors? Cancer (Phila) 98 IssueID4 661–667 Occurrence Handle1:CAS:528:DC%2BD3sXntVWgtbk%3D

    CAS  Google Scholar 

  49. N Tanaka M Ishihara MS Lamphier et al. (1996) ArticleTitleCooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage Nature (Lond) 382 IssueID6594 816–818 Occurrence Handle1:CAS:528:DyaK28XltlWqs7w%3D

    CAS  Google Scholar 

  50. S Ohno T Nishi Y Kojima et al. (2002) ArticleTitleCombined stimulation with interferon alpha and retinoic acid synergistically inhibits proliferation of the glioblastoma cell line GB12 Neurol Res 24 697–704 Occurrence Handle10.1179/016164102101200609 Occurrence Handle1:CAS:528:DC%2BD38XosFWlu7s%3D Occurrence Handle12392208

    Article  CAS  PubMed  Google Scholar 

  51. Z von Marschall A Scholz T Cramer et al. (2003) ArticleTitleEffects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis J Natl Cancer Inst 95 437–448 Occurrence Handle1:CAS:528:DC%2BD3sXisFCrurc%3D Occurrence Handle12644537

    CAS  PubMed  Google Scholar 

  52. JJ Marler JB Rubin NS Trede et al. (2002) ArticleTitleSuccessful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases Pediatrics 109 E37 Occurrence Handle10.1542/peds.109.2.e37 Occurrence Handle11826247

    Article  PubMed  Google Scholar 

  53. L Wang WZ Wu HC Sun et al. (2003) ArticleTitleMechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice J Gastrointest Surg 7 587–594 Occurrence Handle10.1016/S1091-255X(03)00072-6 Occurrence Handle12850669

    Article  PubMed  Google Scholar 

  54. L Wang ZY Tang LX Qin et al. (2000) ArticleTitleHigh-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential Hepatology 32 43–48 Occurrence Handle10.1053/jhep.2000.8525 Occurrence Handle1:CAS:528:DC%2BD3cXltFWgs74%3D Occurrence Handle10869287

    Article  CAS  PubMed  Google Scholar 

  55. Y Muto H Moriwaki A Saito (1999) ArticleTitlePrevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma N Engl J Med 340 IssueID13 1046–1047 Occurrence Handle10.1056/NEJM199904013401315 Occurrence Handle1:STN:280:DyaK1M7ot1agsw%3D%3D Occurrence Handle10189289

    Article  CAS  PubMed  Google Scholar 

  56. MB Sporn N Suh (2000) ArticleTitleChemoprevention of cancer Carcinogenesis (Oxf) 21 IssueID3 525–530 Occurrence Handle1:CAS:528:DC%2BD3cXitVeit7Y%3D

    CAS  Google Scholar 

  57. MW Lingen PJ Polverini NP Bouck (1996) ArticleTitleRetinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic Am J Pathol 149 IssueID1 247–258 Occurrence Handle1:CAS:528:DyaK28XkslKhsbY%3D Occurrence Handle8686749

    CAS  PubMed  Google Scholar 

  58. BV Diaz MC Lenoir A Ladoux et al. (2000) ArticleTitleRegulation of vascular endothelial growth factor expression in human keratinocytes by retinoids J Biol Chem 275 IssueID1 642–650 Occurrence Handle10.1074/jbc.275.1.642 Occurrence Handle1:CAS:528:DC%2BD3cXjvVKnsg%3D%3D Occurrence Handle10617662

    Article  CAS  PubMed  Google Scholar 

  59. M Iurlaro R Benelli L Masiello et al. (1998) ArticleTitleBeta interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid Eur J Cancer 34 IssueID4 570–576 Occurrence Handle10.1016/S0959-8049(97)10082-X Occurrence Handle1:CAS:528:DyaK1cXivFagsbg%3D Occurrence Handle9713311

    Article  CAS  PubMed  Google Scholar 

  60. S Majewski A Szmurlo M Marczak S Jablonska W Bollag (1994) ArticleTitleSynergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines Int J Cancer 57 IssueID1 81–85 Occurrence Handle1:CAS:528:DyaK2cXkvF2hs7g%3D Occurrence Handle7512078

    CAS  PubMed  Google Scholar 

  61. EM Bengtson JR Rigas (1999) ArticleTitleNew oral chemotherapeutic agents for lung cancer Drugs 58 IssueIDsuppl 3 57–69 Occurrence Handle1:CAS:528:DC%2BD3cXhtVemu7s%3D Occurrence Handle10711843

    CAS  PubMed  Google Scholar 

  62. D Ribatti G Alessandri M Baronio et al. (2001) ArticleTitleInhibition of neuroblastoma-induced angiogenesis by fenretinide Int J Cancer 94 IssueID3 314–321 Occurrence Handle10.1002/ijc.1441 Occurrence Handle1:CAS:528:DC%2BD3MXnsVers7w%3D Occurrence Handle11745408

    Article  CAS  PubMed  Google Scholar 

  63. M Kagawa T Sano N Ishibashi et al. (2004) ArticleTitleAn acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation Carcinogenesis (Oxf) 25 IssueID6 979–985 Occurrence Handle1:CAS:528:DC%2BD2cXksVaht7Y%3D

    CAS  Google Scholar 

  64. P Banerjee M Chatterjee (2003) ArticleTitleAntiproliferative role of vitamin D and its analogs: a brief overview Mol Cell Biochem 253 IssueID1–2 247–254 Occurrence Handle1:CAS:528:DC%2BD3sXnslSgsbo%3D Occurrence Handle14619976

    CAS  PubMed  Google Scholar 

  65. DJ Mantell PE Owens NJ Bundred EB Mawer AE Canfield (2000) ArticleTitle1-Alpha, 25-dihydoxyvitamin D3 inhibits angiogenesis in vitro and in vivo Circ Res 87 IssueID3 214–220 Occurrence Handle1:CAS:528:DC%2BD3cXlsFygs7w%3D Occurrence Handle10926872

    CAS  PubMed  Google Scholar 

  66. R Masood S Nagpal T Zheng et al. (2000) ArticleTitleKaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist Blood 96 IssueID9 3188–3194 Occurrence Handle1:CAS:528:DC%2BD3cXnslGntLo%3D Occurrence Handle11050002

    CAS  PubMed  Google Scholar 

  67. K Dalhoff J Dancey L Astrup et al. (2003) ArticleTitleA phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma Br J Cancer 89 IssueID2 252–257 Occurrence Handle10.1038/sj.bjc.6601104 Occurrence Handle1:CAS:528:DC%2BD3sXlsVaktbg%3D Occurrence Handle12865912

    Article  CAS  PubMed  Google Scholar 

  68. BH Park B Breyer TC He (2001) ArticleTitlePeroxisome proliferator-activated receptors: roles in tumorigenesis and chemoprevention in human cancer Curr Opin Oncol 13 IssueID1 78–83 Occurrence Handle10.1097/00001622-200101000-00015 Occurrence Handle1:CAS:528:DC%2BD3MXmsFOgtg%3D%3D Occurrence Handle11148691

    Article  CAS  PubMed  Google Scholar 

  69. X Xin S Yang J Kowalski ME Gerritsen (1999) ArticleTitlePeroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo J Biol Chem 274 IssueID13 9116–9121 Occurrence Handle10.1074/jbc.274.13.9116 Occurrence Handle1:CAS:528:DyaK1MXitFyru7c%3D Occurrence Handle10085162

    Article  CAS  PubMed  Google Scholar 

  70. D Bishop-Bailey T Hla (1999) ArticleTitleEndothelial cell apoptosis induced by peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy delta 12,14-prostaglandin J2 J Biol Chem 274 IssueID24 17042–17048 Occurrence Handle10.1074/jbc.274.24.17042 Occurrence Handle1:CAS:528:DyaK1MXjvVGktbo%3D Occurrence Handle10358055

    Article  CAS  PubMed  Google Scholar 

  71. E Mueller P Sarraf P Tontonoz et al. (1998) ArticleTitleTerminal differentiation of human breast cancer through PPAR-γ Mol Cell 1 465–470 Occurrence Handle10.1016/S1097-2765(00)80047-7 Occurrence Handle1:CAS:528:DyaK1cXhtlyhurk%3D Occurrence Handle9660931

    Article  CAS  PubMed  Google Scholar 

  72. AM Lefebvre I Chen P Desreumaux et al. (1998) ArticleTitleActivation of the proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice Nat Med 4 1053–1057 Occurrence Handle10.1038/2036 Occurrence Handle1:CAS:528:DyaK1cXlvFGgsLw%3D Occurrence Handle9734399

    Article  CAS  PubMed  Google Scholar 

  73. KL Schaefer K Wada H Takahashi et al. (2005) ArticleTitlePeroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells Cancer Res 65 IssueID6 2251–2259 Occurrence Handle10.1158/0008-5472.CAN-04-3037 Occurrence Handle1:CAS:528:DC%2BD2MXisFGgu7c%3D Occurrence Handle15781638

    Article  CAS  PubMed  Google Scholar 

  74. H Hurwitz L Fehrenbacher W Novotny et al. (2004) ArticleTitleBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 IssueID23 2335–2342 Occurrence Handle10.1056/NEJMoa032691 Occurrence Handle1:CAS:528:DC%2BD2cXks1Gjt74%3D Occurrence Handle15175435

    Article  CAS  PubMed  Google Scholar 

  75. D Semela JF Dufour (2004) ArticleTitleAngiogenesis and hepatocellular carcinoma J Hepatol 41 IssueID5 864–880 Occurrence Handle10.1016/j.jhep.2004.09.006 Occurrence Handle15519663

    Article  PubMed  Google Scholar 

  76. Y Liu RT Poon Q Li TW Kok C Lau ST Fan (2005) ArticleTitleBoth antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584 Cancer Res 65 IssueID9 3691–3699 Occurrence Handle1:CAS:528:DC%2BD2MXjslGlu7g%3D Occurrence Handle15867364

    CAS  PubMed  Google Scholar 

  77. D Strumberg H Richly RA Hilger et al. (2005) ArticleTitlePhase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors J Clin Oncol 23 IssueID5 965–972 Occurrence Handle1:CAS:528:DC%2BD2MXit1Ggu7c%3D Occurrence Handle15613696

    CAS  PubMed  Google Scholar 

  78. J Oliner H Min J Leal et al. (2004) ArticleTitleSuppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 Cancer Cell 6 IssueID5 507–516 Occurrence Handle10.1016/j.ccr.2004.09.030 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGlurjP Occurrence Handle15542434

    Article  CAS  PubMed  Google Scholar 

  79. A Hirata S Ogawa T Kometani et al. (2002) ArticleTitleZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase Cancer Res 62 IssueID9 2554–2560 Occurrence Handle1:CAS:528:DC%2BD38XjtlGrsbc%3D Occurrence Handle11980649

    CAS  PubMed  Google Scholar 

  80. M Matsuo H Sakurai I Saiki (2003) ArticleTitleZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model Mol Cancer Ther 2 IssueID6 557–561 Occurrence Handle1:CAS:528:DC%2BD3sXlslWkt7c%3D Occurrence Handle12813135

    CAS  PubMed  Google Scholar 

  81. K Furumoto S Arii S Yamasaki et al. (2000) ArticleTitleSpleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses Int J Cancer 87 IssueID5 665–672 Occurrence Handle10.1002/1097-0215(20000901)87:5<665::AID-IJC8>3.0.CO;2-F Occurrence Handle1:CAS:528:DC%2BD3cXlvFahtbc%3D Occurrence Handle10925360

    Article  CAS  PubMed  Google Scholar 

  82. YI Yamashita M Shimada H Hasegawa et al. (2001) ArticleTitleElectroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model Cancer Res 61 IssueID3 1005–1012 Occurrence Handle1:CAS:528:DC%2BD3MXhsFSru7g%3D Occurrence Handle11221826

    CAS  PubMed  Google Scholar 

  83. MS O'Reilly T Boehm Y Shing et al. (1997) ArticleTitleEndostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 IssueID2 277–285 Occurrence Handle9008168

    PubMed  Google Scholar 

  84. JP Eder SuffixJr JG Supko JW Clark et al. (2002) ArticleTitlePhase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily J Clin Oncol 20 IssueID18 3772–3784 Occurrence Handle10.1200/JCO.2002.02.082 Occurrence Handle1:CAS:528:DC%2BD38XntVyns7w%3D Occurrence Handle12228197

    Article  CAS  PubMed  Google Scholar 

  85. YZ Patt MM Hassan RD Lozano et al. (2005) ArticleTitleThalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial Cancer (Phila) 103 IssueID4 749–755 Occurrence Handle1:CAS:528:DC%2BD2MXit1Ggsrs%3D

    CAS  Google Scholar 

  86. A List S Kurtin DJ Roe et al. (2005) ArticleTitleEfficacy of lenalidomide in myelodysplastic syndromes N Engl J Med 352 IssueID6 549–557 Occurrence Handle10.1056/NEJMoa041668 Occurrence Handle1:CAS:528:DC%2BD2MXhtFemsrc%3D Occurrence Handle15703420

    Article  CAS  PubMed  Google Scholar 

  87. M Niwano S Arii A Mori et al. (1998) ArticleTitleInhibition of tumor growth and microvascular angiogenesis by the potent angiogenesis inhibitor, TNP-470, in rats Surg Today 28 IssueID9 915–922 Occurrence Handle10.1007/s005950050252 Occurrence Handle1:CAS:528:DyaK1cXmsVSiu7Y%3D Occurrence Handle9744400

    Article  CAS  PubMed  Google Scholar 

  88. CR Kapadia (1998) ArticleTitleSomatostatin and hepatocellular carcinoma Gastroenterology 115 IssueID5 1298–1299 Occurrence Handle10.1016/S0016-5085(98)70109-X Occurrence Handle1:STN:280:DyaK1M%2FhsVahtg%3D%3D Occurrence Handle9797392

    Article  CAS  PubMed  Google Scholar 

  89. A Albini T Florio D Giunciuglio et al. (1999) ArticleTitleSomatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis FASEB J 13 IssueID6 647–655 Occurrence Handle1:CAS:528:DyaK1MXit1ers70%3D Occurrence Handle10094925

    CAS  PubMed  Google Scholar 

  90. B St. Croix C Rago V Velculescu et al. (2000) ArticleTitleGenes expressed in human tumor endothelium Science 289 IssueID5482 1197–1202 Occurrence Handle1:CAS:528:DC%2BD3cXmt1WhsLo%3D Occurrence Handle10947988

    CAS  PubMed  Google Scholar 

  91. E Ruoslahti (2002) ArticleTitleSpecialization of tumour vasculature Nat Rev Cancer 2 IssueID2 83–90 Occurrence Handle10.1038/nrc724 Occurrence Handle12635171

    Article  PubMed  Google Scholar 

  92. RS Kerbel BA Kamen (2004) ArticleTitleThe anti-angiogenic basis of metronomic chemotherapy Nat Rev Cancer 4 IssueID6 423–436 Occurrence Handle10.1038/nrc1369 Occurrence Handle1:CAS:528:DC%2BD2cXksVaisbk%3D Occurrence Handle15170445

    Article  CAS  PubMed  Google Scholar 

  93. G Bocci G Francia S Man J Lawler RS Kerbel (2003) ArticleTitleThrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy Proc Natl Acad Sci U S A 100 IssueID22 12917–12922 Occurrence Handle10.1073/pnas.2135406100 Occurrence Handle1:CAS:528:DC%2BD3sXoslKnu7g%3D Occurrence Handle14561896

    Article  CAS  PubMed  Google Scholar 

  94. J Ma S Pulfer S Li et al. (2001) ArticleTitlePharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470 Cancer Res 61 IssueID14 5491–5498 Occurrence Handle1:CAS:528:DC%2BD3MXlsVChsLk%3D Occurrence Handle11454697

    CAS  PubMed  Google Scholar 

  95. S Sengupta D Eavarone I Capila et al. (2005) ArticleTitleTemporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature (Lond) 436 IssueID7050 568–572 Occurrence Handle1:CAS:528:DC%2BD2MXmsFCgs70%3D

    CAS  Google Scholar 

  96. G Gasparini R Longo M Fanelli BA Teicher (2005) ArticleTitleCombination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions J Clin Oncol 23 IssueID6 1295–1311 Occurrence Handle10.1200/JCO.2005.10.022 Occurrence Handle1:CAS:528:DC%2BD2MXitl2gu74%3D Occurrence Handle15718328

    Article  CAS  PubMed  Google Scholar 

  97. F Winkler SV Kozin RT Tong et al. (2004) ArticleTitleKinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases Cancer Cell 6 IssueID6 553–563 Occurrence Handle1:CAS:528:DC%2BD2MXktVantw%3D%3D Occurrence Handle15607960

    CAS  PubMed  Google Scholar 

  98. RK Jain (2005) ArticleTitleNormalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 IssueID5706 58–62 Occurrence Handle10.1126/science.1104819 Occurrence Handle1:CAS:528:DC%2BD2MXnvFar Occurrence Handle15637262

    Article  CAS  PubMed  Google Scholar 

  99. HSN Greene (1941) ArticleTitleHeterologous transplantation of mammalian tumors. The transfer of human tumors of alien species J Exp Med 73 461–486

    Google Scholar 

  100. GH Algire HW Chalkley FY Legallais HD Park (1945) ArticleTitleVascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of normal and neoplastic transplants J Natl Cancer Inst 6 73–85

    Google Scholar 

  101. G Gasparini R Longo M Toi N Ferrara (2005) ArticleTitleAngiogenic inhibitors: a new therapeutic strategy in oncology Nat Clin Pract Oncol 2 IssueID11 562–577 Occurrence Handle1:CAS:528:DC%2BD2MXht1Ghu77F Occurrence Handle16270097

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepato-Biliary-Pancreatic Surgery, Tokyo Medical and Dental University, Graduate School of Medicine, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan

    Shinji Tanaka & Shigeki Arii

Authors
  1. Shinji Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shigeki Arii
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinji Tanaka.

About this article

Cite this article

Tanaka, S., Arii, S. Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma. Int J Clin Oncol 11, 82–89 (2006). https://doi.org/10.1007/s10147-006-0566-5

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-006-0566-5

Key words

Search

Navigation